Literature DB >> 35253073

Dihydrofolate reductase, thymidylate synthase, and serine hydroxy methyltransferase: successful targets against some infectious diseases.

Hina Shamshad1, Rowaida Bakri2, Agha Zeeshan Mirza3.   

Abstract

Parasitic diseases have a serious impact on the world in terms of health and economics and are responsible for worldwide mortality and morbidity. The present review features the hybrid targeting involving three main enzymes for the treatment of different parasitic diseases. The enzymes Dihydrofolate reductase, thymidylate synthase, and Serine hydroxy methyltransferase play an essential role in the folate pathway. The present review focuses on these enzymes, which can be targeted against several diseases. It shed light on the past, present, and future of these targets, and it can be assessed that these targets can play a significant role against several infectious diseases. For combating viral and protozoal infectious diseases, these targets in combination should be addressed.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  And SHMT; DHFR; Infectious diseases; TS

Mesh:

Substances:

Year:  2022        PMID: 35253073      PMCID: PMC8898753          DOI: 10.1007/s11033-022-07266-8

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  70 in total

1.  Insights into antifolate resistance from malarial DHFR-TS structures.

Authors:  Jirundon Yuvaniyama; Penchit Chitnumsub; Sumalee Kamchonwongpaisan; Jarunee Vanichtanankul; Worachart Sirawaraporn; Paul Taylor; Malcolm D Walkinshaw; Yongyuth Yuthavong
Journal:  Nat Struct Biol       Date:  2003-05

2.  Discovery of Selective Toxoplasma gondii Dihydrofolate Reductase Inhibitors for the Treatment of Toxoplasmosis.

Authors:  Allen T Hopper; Adam Brockman; Andy Wise; Julie Gould; Jennifer Barks; Joshua B Radke; L David Sibley; Yongmao Zou; Stephen Thomas
Journal:  J Med Chem       Date:  2019-01-24       Impact factor: 7.446

3.  Novel allosteric covalent inhibitors of bifunctional Cryptosporidium hominis TS-DHFR from parasitic protozoa identified by virtual screening.

Authors:  Victor Ruiz; Daniel J Czyzyk; Margarita Valhondo; William L Jorgensen; Karen S Anderson
Journal:  Bioorg Med Chem Lett       Date:  2019-03-20       Impact factor: 2.823

Review 4.  Folates in Trypanosoma brucei: Achievements and Opportunities.

Authors:  Gregorio Cullia; Lucia Tamborini; Paola Conti; Carlo De Micheli; Andrea Pinto
Journal:  ChemMedChem       Date:  2018-09-24       Impact factor: 3.466

5.  Potent and selective activity of a combination of thymidine and 1843U89, a folate-based thymidylate synthase inhibitor, against Plasmodium falciparum.

Authors:  L Jiang; P C Lee; J White; P K Rathod
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

6.  Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target.

Authors:  Yongyuth Yuthavong; Bongkoch Tarnchompoo; Tirayut Vilaivan; Penchit Chitnumsub; Sumalee Kamchonwongpaisan; Susan A Charman; Danielle N McLennan; Karen L White; Livia Vivas; Emily Bongard; Chawanee Thongphanchang; Supannee Taweechai; Jarunee Vanichtanankul; Roonglawan Rattanajak; Uthai Arwon; Pascal Fantauzzi; Jirundon Yuvaniyama; William N Charman; David Matthews
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-03       Impact factor: 11.205

7.  Toxoplasmosis: a global threat.

Authors:  João M Furtado; Justine R Smith; Rubens Belfort; Devin Gattey; Kevin L Winthrop
Journal:  J Glob Infect Dis       Date:  2011-07

8.  A pyrazolopyran derivative preferentially inhibits the activity of human cytosolic serine hydroxymethyltransferase and induces cell death in lung cancer cells.

Authors:  Marina Marani; Alessio Paone; Alessio Fiascarelli; Alberto Macone; Maurizio Gargano; Serena Rinaldo; Giorgio Giardina; Valentino Pontecorvi; David Koes; Lee McDermott; Tianyi Yang; Alessandro Paiardini; Roberto Contestabile; Francesca Cutruzzolà
Journal:  Oncotarget       Date:  2016-01-26

9.  Identification of Plasmodium falciparum specific translation inhibitors from the MMV Malaria Box using a high throughput in vitro translation screen.

Authors:  Vida Ahyong; Christine M Sheridan; Kristoffer E Leon; Jessica N Witchley; Jonathan Diep; Joseph L DeRisi
Journal:  Malar J       Date:  2016-03-17       Impact factor: 2.979

10.  Design strategy for serine hydroxymethyltransferase probes based on retro-aldol-type reaction.

Authors:  Hiroshi Nonaka; Yuki Nakanishi; Satoshi Kuno; Tomoki Ota; Kentaro Mochidome; Yutaro Saito; Fuminori Sugihara; Yoichi Takakusagi; Ichio Aoki; Satoru Nagatoishi; Kouhei Tsumoto; Shinsuke Sando
Journal:  Nat Commun       Date:  2019-02-20       Impact factor: 14.919

View more
  2 in total

1.  Cinnamomum zeylanicum Extract and its Bioactive Component Cinnamaldehyde Show Anti-Tumor Effects via Inhibition of Multiple Cellular Pathways.

Authors:  Sadhna Aggarwal; Kanchan Bhadana; Baldeep Singh; Meenakshi Rawat; Taj Mohammad; Lamya Ahmed Al-Keridis; Nawaf Alshammari; Md Imtaiyaz Hassan; Satya N Das
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

2.  In Silico Prediction of Plasmodium falciparum Cytoadherence Inhibitors That Disrupt Interaction between gC1qR-DBLβ12 Complex.

Authors:  Abdul Hafiz; Rowaida Bakri; Mohammad Alsaad; Obadah M Fetni; Lojain I Alsubaihi; Hina Shamshad
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.